# Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

> **NCT00362141** · PHASE2 · UNKNOWN · sponsor: **Medical Center Haaglanden** · enrollment: 12 (—)

## Conditions studied

- Status Epilepticus

## Interventions

- **DRUG:** levetiracetam (add-on)

## Key facts

- **NCT ID:** NCT00362141
- **Lead sponsor:** Medical Center Haaglanden
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 12 (—)
- **Last updated:** 2007-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362141, "Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus". Retrieved via MORVS 2026-10-28 from https://api.morvs.ai/clinical/NCT00362141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*